Ohad Mazor
Impact in
- Biotechnology top 5%
- Transgenic Plants and Applications
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
Papers in
-
- Transgenic Plants and Applications 13
- Cancer Research and Treatments 5
- Immunology 19
- Toxin Mechanisms and Immunotoxins 16
- Co-authors
- Avigdor Joshua Scherz (11 shared papers)Yoram Salomon (11 shared papers)Chanoch Kronman (17 shared papers)Alexander S. Brandis (6 shared papers)Eran Neumark (6 shared papers)Varda Rosenbach‐Belkin (6 shared papers)Ron Alcalay (24 shared papers)Ofer Cohen (9 shared papers)
In The Last Decade
Ohad Mazor
61 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Biotechnology 221
- Infectious Diseases 454
- Immunology 346
- Pulmonary and Respiratory Medicine 304
- Animal Science and Zoology 89
Countries citing papers authored by Ohad Mazor
This map shows the geographic impact of Ohad Mazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ohad Mazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ohad Mazor more than expected).
Fields of papers citing papers by Ohad Mazor
This network shows the impact of papers produced by Ohad Mazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ohad Mazor. The network helps show where Ohad Mazor may publish in the future.
Co-authors
The 25 scholars most cited alongside Ohad Mazor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 183 | |
| 2 | 2005 | 123 | |
| 3 | 2020 | 109 | |
| 4 | 2005 | 92 | |
| 5 | 2006 | 56 | |
| 6 | 2014 | 47 | |
| 7 | 2021 | 45 | |
| 8 | 2021 | 45 | |
| 9 | 2017 | 45 | |
| 10 | 2004 | 43 | |
| 11 | 2016 | 38 | |
| 12 | 2015 | 35 | |
| 13 | 2016 | 35 | |
| 14 | 2003 | 34 | |
| 15 | 2005 | 31 | |
| 16 | 2021 | 30 | |
| 17 | 2009 | 29 | |
| 18 | 2015 | 27 | |
| 19 | 2006 | 27 | |
| 20 | 2002 | 24 |
About Ohad Mazor
Ohad Mazor is a scholar working on Biotechnology, Immunology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 61 papers that have together received 1.5k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (16 papers), Transgenic Plants and Applications (13 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Nanoplatforms for cancer theranostics (8 papers), Photodynamic Therapy Research Studies (8 papers), Bacillus and Francisella bacterial research (8 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Biotechnology (221 citations), Infectious Diseases (454 citations), Immunology (346 citations), Pulmonary and Respiratory Medicine (304 citations) and Animal Science and Zoology (89 citations). Ohad Mazor has collaborated with scholars based in Israel, Poland and France. Frequent co-authors include Avigdor Joshua Scherz, Yoram Salomon, Chanoch Kronman, Alexander S. Brandis, Eran Neumark, Varda Rosenbach‐Belkin, Ron Alcalay, Ofer Cohen, Adva Mechaly and Tamar Sabo. Their work appears in journals such as Photochemistry and Photobiology, Antibodies, Toxins, Nature Communications and Microbiology Spectrum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.